Saul brings almost 30 years of global clinical, commercial and governance experience in the healthcare and life sciences industries, having practice medicine in South Africa and the United Kingdom, been commercially responsible for the successful global launch of a $1BN+ annual revenue device delivered biotechnology product, and has led various advisory practices/firms focused on the regulatory, compliance, disputes and investigations.

As an independent monitor and independent compliance expert to Life Sciences companies under government scrutiny and/or enforcement, Saul regularly interacts with the Office of Inspector General – Health and Human Services, the Department of Justice and the Drug Enforcement Agency.

Saul brings this unique experience of clinical, commercial and compliance experience to his support of governance within the industry.

Speaking regularly at industry conferences, Saul has also published extensively on the role of the Board of Directors as it relates to their fiduciary responsibilities and healthcare compliance.

Hosted on Acast. See acast.com/privacy for more information.

#308: Saul B. Helman - President Epsilon Life Sciences